Gelatin
Vaccine ingredients
[2016 Sept] Vaccine-glyphosate link exposed by Anthony Samsel
[2010 Feb] Big Pharma/Lancet Scam: Vaccine-Autism Link Denied by MIKE ADAMS/ DR. LEONARD HOROWITZ In recent days, a new study from The Center for Modeling Optimal Outcomes in New Jersey published, "If it hadn't been for so many parents insisting that vaccines were responsible for the condition [of autism], we might never have found the fact that the stabilizer in MMR, and a few other vaccines, is hydrolyzed gelatin--a substance that is approximately 21% glycine. It appears that, based on readily verifiable science, the use of that form of glycine triggers an imbalance between the amino acid neurotransmitters responsible for the absorption rate of certain classes of cells throughout the body. It is that wide-spread disruption that apparently results in the systemic problems that encompass the mind and the body characterized in today's 'classic' autism."
"I am surprised at how comfortable GPs seem to be sitting with any vaccination that has so little research on its components, especially in light of CJD. For example, both the FDA and Medicines Control Agency are reviewing the use of gelatin in pharmaceutical products in an attempt to minimise the risk, with the FDA actually banning its use in intravenous products. (7,8&9) However, they clearly think that there is a risk worth some consideration, so why are our GPs being so dismissive? "---Carol A Teasdale
Rare MMR vaccine reactions often due to gelatin
The Food and Drug Administration (FDA [Federal Register: March 8, 1999
(Volume 64, Number 44)] List of Drug Products That Have Been Withdrawn
or Removed From the Market for Reasons of Safety or Effectiveness http://www.fda.gov/cder/pharmcomp/pcwd.txt
The Sourcing and Processing of Gelatin to Reduce the
Potential Risk Posed by Bovine Spongiform Encephalopathy (BSE) in FDA-Regulated
Products for Human Use September1977 http://www.fda.gov/opacom/morechoices/industry/guidance/gelguide.htm
Summary of the Meeting of the Committee on Safety of Medicines Sub -committee on
Chemistry, Pharmacy and Standards. 3/6/1999 http://www.mca.gov.uk/
Kumagai
T, Yamanaka T, Wataya Y, Umetsu A, Kawamura N, Ikeda K, Furukawa H, Kimura K, Chiba S,
Saito S, Sugawara N, Kurimoto F,
Kamiya
H, Ito M.Update on varicella vaccine.Curr Opin
Pediatr. 1999 Feb;11(1):3-8. Review.PMID: 10084076 [PubMed - indexed for MEDLINE]
Miyazawa
H, Saitoh S, Kumagai T, Yamanaka T, Yasuda S, Tsunetsugu-Yokota Y, Inouye S, Sakaguchi M.Specific
IgG to gelatin in children with systemic immediate- and nonimmediate-type reactions to
measles, mumps and rubella vaccines.Vaccine. 1999 Apr
23;17(17):2176-80.PMID: 10367951 [PubMed - indexed for MEDLINE]
Sakaguchi
M, et al. IgE-mediated systemic reactions to gelatin included
in the varicella vaccine. J Allergy Clin Immunol. 1997 Feb;99(2):263-4. No abstract
available.PMID: 9042057; UI: 97194619
Sakaguchi
M, Miyazawa H, Inouye S.Sensitization to gelatin in children with
systemic non-immediate-type reactions to varicella vaccines.Ann Allergy Asthma Immunol. 2000 Mar;84(3):341-4.PMID: 10752920 [PubMed - indexed for
MEDLINE]
Sakaguchi
M, Yoshida T, Asahi T, Aoki T, Miyatani Y, Inouye S.Development of IgE
antibody to gelatin in children with systemic immediate-type reactions to vaccines.J Allergy Clin Immunol. 1997 May;99(5):720-1. No abstract available.PMID: 9155843
[PubMed - indexed for MEDLINE]
Sakaguchi
M, Nakayama T, Inouye S.Food allergy to gelatin in children with
systemic immediate-type reactions, including anaphylaxis, to vaccines.J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1058-61.PMID: 8977505 [PubMed -
indexed for MEDLINE]
Sakaguchi
M, Miyazawa H, Inouye S. Specific IgE and IgG to gelatin in
children with systemic cutaneous reactions to Japanese encephalitis vaccines.Allergy. 2001 Jun;56(6):536-9.PMID: 11421899 [PubMed - indexed for MEDLINE]
Sakaguchi
M, Inouye S.Systemic allergic reactions to gelatin included in vaccines
as a stabilizer. Jpn J Infect Dis. 2000 Oct;53(5):189-95.
Review.PMID: 11135703 [PubMed - indexed for MEDLINE]
Sakaguchi
M, Nakayama T, Fujita H, Toda M, Inouye S.Minimum estimated incidence in
Japan of anaphylaxis to live virus vaccines including gelatin.Vaccine.
2000 Oct 15;19(4-5):431-6.PMID: 11027805 [PubMed - indexed for MEDLINE]
Sakaguchi M, Inouye S.Gelatin-specific humoral and cellular immune
responses in children with immediate- and nonimmediate-type reactions to live measles,
mumps, rubella, and varicella vaccines.J Allergy Clin Immunol. 1997
Jul;100(1):130-4.PMID: 9257797 [PubMed - indexed for MEDLINE]
Sakaguchi
M, Yoshida M, Kuroda W, Harayama O, Matsunaga Y, Inouye S.Systemic
immediate-type reactions to gelatin included in Japanese encephalitis vaccines.Vaccine. 1997 Feb;15(2):121-2.PMID: 9066026 [PubMed - indexed for MEDLINE]
Sakaguchi
M, Inouye S.IgE sensitization to gelatin: the probable role of
gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines.Vaccine. 2000 Apr 3;18(19):2055-8.PMID: 10706969 [PubMed - indexed for MEDLINE]
Sakaguchi
M, Nakayama T, Inouye S.Cases of systemic immediate-type urticaria
associated with acellular diphtheria-tetanus-pertussis vaccination.Vaccine.
1998 Jul;16(11-12):1138-40.PMID: 9682371 [PubMed - indexed for MEDLINE]
Singer S, Johnson CE, Mohr R, Holowecky C.Urticaria following varicella vaccine associated with gelatin allergy.Vaccine. 1999 Jan 28;17(4):327-9.PMID: 9987170 [PubMed - indexed for MEDLINE
[Home]